OTERKUS, MESUTDelen, Leman AcunKasapoglu, Umut Sabri2025-10-242025-10-2420222548-0669https://doi.org/10.14744/GKDAD.2021.50455https://search.trdizin.gov.tr/tr/yayin/detay/1166505https://hdl.handle.net/20.500.12899/2217Objectives: The purpose of this study is to investigate the effects of pneumothorax (PX), a rare complication of COVID-19, on mortality. Methods: All patients admitted to our hospital with the diagnosis of COVID-19 were screened, and patients who developed PX were includ- ed in the study. Patient demographics data, number of days of hospital- ization for comorbidities, day and duration of thorax tube insertion, and laboratory findings during hospitalization were recorded by scanning the hospital automation system and patient records. Results: For our study, 7485 patients hospitalized with the diagno- sis of COVID-19 were screened in intensive care unit. PX was de - tected in 32 (0.296%) of the patients. About 59.4% of these patients included in the study were male. DM was the most common co - morbid condition at 56.3%. In these patients, the mortality rate was found to be 90.6%. Conclusion: The data obtained indicate that PX, a COVID-19 complica- tion, leads to a serious increase in mortality. We believe that using pro- tective ventilation methods to avoid the development of pneumotarax will help to reduce mortality.eninfo:eu-repo/semantics/openAccessSolunum SistemiSağlık Politikaları ve HizmetleriAcil TıpTemel Sağlık HizmetleriYoğun BakımTıpArticle10.14744/GKDAD.2021.504552843573611166505